To test how our CAR T cell products respond to cell targets displaying lower levels of CD20 expression, HEK293T cells were modified to ectopically express CD20 and two monoclones, F6 and B3, having lower CD20 expression compared to the CD19+ CD20+ lymphoma Raji cell line were obtained (Figure S3). Here, CD19 is linked to lymphoma.